Inovalon Announces First Quarter 2021 Earnings Conference Call

Rhea-AI Summary

Inovalon (Nasdaq: INOV) will hold a conference call on April 28, 2021, at 5:00 p.m. ET to discuss its Q1 2021 financial results. The results will be released after market close on the same day. Investors can access the call by dialing (855) 783-2604 or (631) 485-4882 for international calls, using conference ID 3581518. A replay will be available on Inovalon's website. Inovalon provides cloud-based platforms for data-driven healthcare and serves a wide range of clients, including major health plans, pharma companies, and healthcare systems.

Positive

• Upcoming conference call to discuss Q1 2021 financial results may indicate transparency and engagement with investors.
• Inovalon serves all top 25 U.S. health plans and leading global pharma companies, showcasing strong market position.

Negative

• None.

BOWIE, Md., April 14, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a conference call for investors on Wednesday, April 28, 2021, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the Company’s first quarter 2021 financial results, which will be announced via press release after the close of market trading.

The conference call can be accessed by dialing (855) 783-2604, conference ID 3581518; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com.

About Inovalon

Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE^® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action^®.” Supporting thousands of clients, including all 25 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 574,000 clinical facilities, 332 million Americans, and 61 billion medical events. For more information, visit www.inovalon.com.

Contact:

Kim E. Collins
Senior Vice President, Corporate Communications
kcollins@inovalon.com
301-809-4000 x1473

Hulus Alpay
Vice President, Investor Relations
halpay@inovalon.com
301-809-4000 x1237

FAQ

When will Inovalon announce its first quarter 2021 financial results?

Inovalon will announce its Q1 2021 financial results on April 28, 2021, after market close.

How can I access Inovalon's investor conference call?

The conference call can be accessed by dialing (855) 783-2604, or (631) 485-4882 for international callers, using conference ID 3581518.

What is the significance of the upcoming conference call for INOV shareholders?

The conference call will provide insights into Inovalon's financial performance and future outlook, which are crucial for shareholders.

What type of clients does Inovalon serve?

Inovalon serves a variety of clients including all top 25 U.S. health plans, 22 of the top 25 global pharmaceutical companies, and many healthcare providers.